Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on stimulating amyloid clearance in cerebral amyloid angiopathy, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Leiden University Medical Center | Conditions: Cerebral Amyloid Angiopathy | Phase 2 | Status: ENROLLING_BY_INVITATION